4//SEC Filing
Vargeese Chandra 4
Accession 0000950170-24-086173
CIK 0001631574other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 5:54 PM ET
Size
7.3 KB
Accession
0000950170-24-086173
Insider Transaction Report
Form 4
Vargeese Chandra
See Remarks
Transactions
- Exercise/Conversion
Share Option (right to buy)
2024-07-22−68,210→ 75,332 totalExercise: $2.48Exp: 2025-03-10→ Ordinary Shares (68,210 underlying) - Exercise/Conversion
Ordinary Shares
2024-07-22$2.48/sh+68,210$169,161→ 185,061 total
Footnotes (2)
- [F1]Includes 2,559 ordinary shares acquired on July 14, 2023, 4,135 ordinary shares acquired on January 14, 2024, and 3,533 ordinary shares acquired on July 14, 2024, under the issuer's 2019 Employee Share Purchase Plan.
- [F2]The share options that were exercised via cash purchase in this reportable transaction were fully vested.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001657675
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 5:54 PM ET
- Size
- 7.3 KB